IncontiLase® is a patent-pending, non-invasive Er:YAG laser therapy for the treatment of mild and moderate stress urinary incontinence, based on non-ablative photothermal stimulation of collagen neogenesis, shrinking and tightening of vaginal mucosa tissue and collagen-rich endopelvic fascia, and subsequently greater support to the bladder.
The indications for IncontiLase therapy are mild and moderate stress- and mixed-urinary incontinence (SUI). Preliminary clinical studies show that it is an efficient, easy-to-perform and safe procedure.
How does IncontiLase® work?
Fotona’s 2940 nm Er:YAG non-ablative laser with proprietary “Smooth-mode” technology thermally affects the vaginal tissue, stimulating collagen remodeling and the synthesis of new collagen fibers in the region of the vestibule and urethral orifice, as well as in the area along the anterior vaginal wall.